Bruno F. Fernandes: Argumento Institute, Canada
Vikas Khetan: Flaum Eye Institute, USA
Submission Status: Open | Submission Deadline: 15 February 2024
BMC Ophthalmology is calling for submissions to our Collection on "Retinoblastoma and ocular oncology: current advances and management".
Retinoblastoma is a rare but devastating form of eye cancer primarily affecting children. Recent advances in ocular oncology, have led to significant improvements in the management and treatment of this disease. Chemotherapy, radiation therapy, and surgery can be used to effectively manage retinoblastoma, preserving vision, and preventing metastasis. Moreover, advances in genetic testing and molecular diagnostics have allowed for a better understanding of the molecular basis of retinoblastoma and provided more precise prognostic information, leading to personalized treatment strategies. Despite these advances, managing retinoblastoma remains challenging, particularly in cases where the cancer has spread beyond the eye.
This Collection aims to collate original research articles regarding the current advances and management of retinoblastoma in the field of ocular oncology.